AU7 nanoclusters

AU7 nanoclusters has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Nov 1, 2026: “Nanotherapy rejuvenating mitochondria via SIRT1 ubiquitination suppression attenuates glucolipotoxicity and promotes diabetic bone regeneration”.

Intervention

1 paper studies it1 findingUpdated

1 new paper in 30 daysSee all 1 papers on AU7 nanoclusters

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: National Natural Science Foundation of China
  • Animals1

What did studies of AU7 nanoclusters find?

1

Studies of AU7 nanoclusters measured one outcome, SIRT1 ubiquitin-mediated degradation.

SIRT1 ubiquitin-mediated degradation

downin human cells1

1 study
  1. AU7 nanoclusters inhibit SIRT1 ubiquitin-mediated degradation in human cells.

    “Au7 NCs co-localize with silent information regulator 1 (SIRT1) in the perimitochondrial region and suppress its ubiquitin-mediated degradation.”

    Cellsnanoclusters

    Nanotherapy rejuvenating mitochondria via SIRT1 ubiquitination suppression attenuates glucolipotoxicity and promotes diabetic bone regeneration

    Chemical engineering journal (Lausanne, Switzerland : 1996)

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months